Loophole Offers Pfizer Inc. A Risky Way Back Into A Deal With AstraZeneca PLC

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Pfizer has a risky way back into a deal with AstraZeneca. An apparent loophole in Britain’s takeover code means that the American pharmaceutical giant could offer the 58.85 pounds-a-share demanded by Astra for a recommendation, even after declaring that the earlier £55-a-share pitch was “final.”

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC